STAT - Reporting from the frontiers of health and medicine

Skip to Main Content

Explore what it takes to make the health care system work.

Explore what it takes to make the health care system work.

April 13, 2024

Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
April 12, 2024

Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
April 12, 2024

H5N1 bird flu in U.S. cattle: A wake-up call to action
April 12, 2024

Up and down the ladder: The latest comings and goings
April 12, 2024

What about the company Vertex didn’t buy?
April 12, 2024

European regulators find no evidence of link between new obesity medicines and suicidal thoughts

The Obesity Revolution

Hospitals that make profits should pay taxes

Most hospitals pay no taxes. The IRS community benefit standard allows nonprofit hospitals to inflate charity care, avoid taxes.

In the Lab April 11, 2024

STAT Plus: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way

Politics April 10, 2024

STAT Plus: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain

Hospitals April 8, 2024

STAT Plus: HCA reports almost $1 billion more in charity care to Medicare than to its shareholders, drawing more taxpayer money

Health April 12, 2024

High physician empathy could offer patients with lower back pain lasting benefits, study shows

Sponsored

Advertisement

All First Opinion

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

Harvard longevity scientist sparks furor with claim about reversing aging in dogs

When a cancer drug fails, oncologists often fly blind. A precision technique might light the way

FTC cracks down on telehealth addiction service Monument for sharing health data

Cancer is rising among the young. Study suggests it’s because their cells are aging faster

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

STAT in DC: Policy in Health Care

Washington, DC April 29, 2024

Join STAT’s DC bureau alongside policymakers, advocates, & industry experts to discuss the biggest policy issues shaping health care.

16

May

2024 STAT Breakthrough Summit West

San Francisco, CA

31

May

STAT@ASCO: Pathways to Progress

Chicago, IL

18

Apr

Family Caregivers: Critical Members of the Care Team

Virtual

All Events

More Stories

Letters to the editor April 13, 2024

Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more

Pharmalot April 12, 2024

STAT Plus: Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps

First Opinion April 12, 2024

H5N1 bird flu in U.S. cattle: A wake-up call to action

Pharmalot April 12, 2024

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout April 12, 2024

What about the company Vertex didn’t buy?

Health April 12, 2024

European regulators find no evidence of link between new obesity medicines and suicidal thoughts

First Opinion April 12, 2024

Needed for reproductive justice and autonomy: women in design

In the Lab April 12, 2024

What the noses of mice can tell us about the inheritance of trauma

First Opinion April 12, 2024

Congress: Protect patients and enact the Nuclear Medicine Clarification Act

Health tech April 11, 2024

STAT Plus: FTC cracks down on telehealth addiction service Monument for sharing health data

The Readout LOUD April 11, 2024

Vertex’s big deal, biotech’s red numbers, & an industry history lesson

The Readout April 11, 2024

STAT Plus: Gas prices are hurting biotech

Pharmalot April 12, 2024

STAT Plus: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more

Adam's Biotech Scorecard April 11, 2024

STAT Plus: The inside story of Enhertu’s pan-tumor approval

Pharmalot April 11, 2024

STAT Plus: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more

Politics April 11, 2024

STAT Plus: $10 billion long Covid ‘moonshot’ is being floated by Bernie Sanders

Health tech April 11, 2024

STAT Plus: Telehealth providers can drive antibiotic overuse — or choose to combat it

Exclusive April 11, 2024

STAT Plus: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

Letters to the editor April 13, 2024

Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more

First Opinion April 12, 2024

Congress: Protect patients and enact the Nuclear Medicine Clarification Act

First Opinion April 11, 2024

To rebuild trust in public health: Better communication, fewer mandates, and small wins

First Opinion April 10, 2024

Mental health screening tools for kids are 30 years out of date

First Opinion April 10, 2024

Cancer is a killer. So is the fear of it

First Opinion April 9, 2024

As a rule, rape exceptions for abortion don’t work

Newsletters

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

STAT Plus: The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform

STAT Plus: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives

By Jason Mast and Megan Molteni

A study says intermittent fasting is making people drop dead. Oh, come on

By Matthew Herper

STAT Plus: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

The evidence is clear: A liquid-only diet before a colonoscopy is unnecessary

By Benjamin Lebwohl

STAT Plus: Hospitals turn to sports performance centers to offer athletes elite care — for the right price

By Elizabeth Cooney

STAT Plus: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic

STAT Plus: Vertex to buy Alpine Immune Sciences for $4.9 billion

Biotech April 10, 2024

STAT Plus: Vertex to buy Alpine Immune Sciences for $4.9 billion

Biotech April 10, 2024

STAT Plus: Cancer vaccines gain momentum, after years of disappointing results

Biotech April 9, 2024

STAT Plus: Biotech startups post strongest financing numbers in two years

STAT Plus: Drug shortages reached a record high as 2023 drew to a close

Pharmalot April 11, 2024

STAT Plus: Drug shortages reached a record high as 2023 drew to a close

Pharmalot April 10, 2024

STAT Plus: Regeneron accused by Justice Department of manipulating Medicare pricing

Pharmalot April 10, 2024

STAT Plus: Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more

Medicaid redetermination cost community health centers an average of $600K each

Health April 8, 2024

Medicaid redetermination cost community health centers an average of $600K each

Health April 7, 2024

STAT Plus: About half of cancer drugs given accelerated approval don’t show improved survival or quality of life

Health April 7, 2024

Large trial challenges common practice of prescribing beta blockers after heart attack

STAT Plus: BIO’s top lobbyist exits, signaling reorganization

Politics April 10, 2024

STAT Plus: BIO’s top lobbyist exits, signaling reorganization

Politics April 4, 2024

STAT Plus: Nuclear Regulatory Commission advisers beset by conflicts of interest, report finds

Politics April 2, 2024

STAT Plus: The White House has a plan to stem drug shortages

Video

STAT Plus: Medicare billing forms are running out of space for growing health care prices

Watch: Why fentanyl withdrawal is agony and how medication can prevent it

What is in utero gene editing?

Treating Rural America: The telehealth solution

War on Recovery

War on Recovery

STAT Plus: Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing

Health tech April 9, 2024

STAT Plus: Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing

Health tech April 8, 2024

STAT Plus: Device made by company J&J is buying for $13 billion clears hurdle in independent study

Health tech April 7, 2024

STAT Plus: In first big randomized trial, Abiomed’s heart pump reduced deaths in heart attack patients

STAT Plus: New liquid biopsy screening test for pancreatic cancer shows promise in early data

In the Lab April 8, 2024

STAT Plus: New liquid biopsy screening test for pancreatic cancer shows promise in early data

In the Lab April 1, 2024

STAT Plus: Scientists uncover potential path to treating deadly childhood tumor

In the Lab March 29, 2024

Why researchers think human milk could repair the gut microbiome and reduce infections

STAT Plus: Mass. senators assail Steward Health Care during hearing on firm’s struggling hospitals

Hospitals April 3, 2024

STAT Plus: Mass. senators assail Steward Health Care during hearing on firm’s struggling hospitals

Hospitals April 1, 2024

STAT Plus: UnitedHealth’s surprising new target: Struggling Steward’s physician group

Hospitals March 26, 2024

STAT Plus: Some nonprofit hospitals spend less on charity care than they receive in tax breaks, new analysis shows

STAT Plus: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers

Insurance April 9, 2024

STAT Plus: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers

Insurance April 1, 2024

STAT Plus: Biden administration sticks with slight cuts to 2025 Medicare Advantage payments

Insurance March 25, 2024

STAT Plus: Medicare Advantage insurers pressure Biden administration for bigger payments

Podcasts

Vertex’s big deal, biotech’s red numbers, & an industry history lesson

Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise

What the mifepristone case means, GLP-1 skepticism, & Chinese biotech

Live! From the STAT Breakthrough Summit East